ROLE OF MITOCHONDRIAL-PRODUCED ROS IN NEUROGENIC HYPERTENSION
线粒体产生的 ROS 在神经源性高血压中的作用
基本信息
- 批准号:7960361
- 负责人:
- 金额:$ 16.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-01 至 2010-07-31
- 项目状态:已结题
- 来源:
- 关键词:Angiotensin IIAntioxidantsBaroreflexBiochemicalBiologicalBiologyBlood - brain barrier anatomyBrainBrain regionCardiovascular DiseasesCardiovascular systemCell Culture TechniquesCellsComputer Retrieval of Information on Scientific Projects DatabaseDevelopmentDiseaseFree RadicalsFundingGene TransferGenerationsGoalsGrantHeart failureHypertensionIn VitroInstitutionLeadLocationMeasuresMediatingMitochondriaModelingMolecularNADPH OxidaseNeuraxisNeuronsOrganOutputOxidantsOxidation-ReductionPathogenesisPhysiologicalPlayReactive Oxygen SpeciesResearchResearch PersonnelResourcesRoleSeriesSignal TransductionSiteSourceTechniquesTestingUnited States National Institutes of HealthVasopressinsadenoviral-mediatedbrain cellchronotropicin vivomouse modelneurogenic hypertensionnoveloverexpressionpreventresearch studytherapeutic target
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Dysregulation of brain angiotensin II (AngII) signaling is implicated in the pathogenesis of cardiovascular diseases, including heart failure and hypertension. Increased circulating levels of AngII can lead to the development of neurogenic hypertension by acting on specialized brain regions known as circumventricular organs, which lack a blood-brain-barrier, and altering central cardiovascular outputs including sympathoexcitation, release of vasopressin, and dampening of baroreflexes. To better understand the central actions of AngII in the development of neurogenic hypertension and to identify novel, central therapeutic targets of the disease, it is essential to investigate the signaling mechanisms of AngII in the central nervous system (CNS). Previously, reactive oxygen species (ROS) generated by NADPH oxidase have been identified as important signaling intermediates in central AngII-mediated cardiovascular effects. Although NADPH oxidase has been shown to be a critical source of ROS, additional sources including mitochondria, which are the primary sites for ROS generation in most cells, have yet to be investigated. Herein, we propose a series of in vitro molecular biological and biochemical studies and in vivo integrative cardiovascular physiological experiments to test the novel hypothesis that mitochondrial-produced ROS play a fundamental role in brain angiotensinergic signaling, and that overexpression of mitochondrial-targeted antioxidants in CNS cardiovascular control regions ameliorates neurogenic hypertension. Using CNS-derived primary neurons, as well as an AngII-sensitive neuronal cell culture model we will measure ROS levels specifically in mitochondria following AngII stimulation. In addition, we will use adenoviral-mediated gene transfer of mitochondrial-targeted antioxidants to examine the effects of mitochondrial-produced ROS on the chronotropic action of AngII in neurons using electrophysiological techniques. Finally, using an experimental mouse model of AngII-dependent neurogenic hypertension we will determine the role of mitochondrial-produced ROS in the CNS in the pathogenesis of the disease. These studies will provide new information on the intra-neuronal signaling mechanisms of AngII, and may identify mitochondrial-produced ROS as important therapeutic targets in neurogenic hypertension.
Lay Description: Heart failure and hypertension are two cardiovascular diseases associated with abnormal stimulation in the brain. Free radicals and oxidants produced in brain cells called neurons have been shown to be involved in these cardiovascular diseases. The primary goal of this study is to use antioxidants, which are found in a specific cellular location (mitochondria), to prevent the development of hypertension.
这个子项目是众多研究子项目之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Matthew C. Zimmerman其他文献
Nanoformulated Copper/Zinc Superoxide Dismutase Increases Neuronal Uptake Via Active Endocytosis
- DOI:
10.1016/j.freeradbiomed.2010.10.565 - 发表时间:
2010-01-01 - 期刊:
- 影响因子:
- 作者:
Erin G. Rosenbaugh;Devika S. Manickam;Elena V. Batrakova;Alexander V. Kabanov;Matthew C. Zimmerman - 通讯作者:
Matthew C. Zimmerman
64 - Inverse Regulatory Effects of Mitochondrial Superoxide in Resting and Activated T-Lymphocytes
- DOI:
10.1016/j.freeradbiomed.2015.10.103 - 发表时间:
2015-10-01 - 期刊:
- 影响因子:
- 作者:
Adam J. Case;Matthew C. Zimmerman - 通讯作者:
Matthew C. Zimmerman
2 - Oxidant- Antioxidant Status in Workers Occupationally Exposed to Long Term Low Levels of Ionizing Radiation- A Pilot Study
- DOI:
10.1016/j.freeradbiomed.2015.10.038 - 发表时间:
2015-10-01 - 期刊:
- 影响因子:
- 作者:
Iman M. Ahmad;James B. Temme;Maher Y. Abdalla;Matthew C. Zimmerman - 通讯作者:
Matthew C. Zimmerman
Overexpression of Manganese Superoxide Dismutase (MnSOD) Attenuates Angiotensin II (AngII)-Induced Inhibition of Protein Phosphatase 2A (PP2A) Activity in Central Neurons
- DOI:
10.1016/j.freeradbiomed.2012.10.423 - 发表时间:
2012-11-01 - 期刊:
- 影响因子:
- 作者:
Urmi Basu;Matthew C. Zimmerman - 通讯作者:
Matthew C. Zimmerman
Nanoformulated Copper/zinc Superoxide Dismutase (CuZnSOD) Inhibits the Central Angiotensin II (AngII)-Induced Pressor Response
- DOI:
10.1016/j.freeradbiomed.2012.10.478 - 发表时间:
2012-11-01 - 期刊:
- 影响因子:
- 作者:
Erin Rosenbaugh;Jun Tian;Devika S. Manickam;Alexander V. Kabanov;Matthew C. Zimmerman - 通讯作者:
Matthew C. Zimmerman
Matthew C. Zimmerman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Matthew C. Zimmerman', 18)}}的其他基金
A NANOZYME ANTIOXIDANT THERAPY FOR THE TREATMENT OF ANGIOTENSIN II-DEPENDANT HYP
用于治疗血管紧张素 II 依赖性 HYP 的纳米酶抗氧化疗法
- 批准号:
8360238 - 财政年份:2011
- 资助金额:
$ 16.63万 - 项目类别:
ELECTRON PARAMAGNETIC RESONANCE (EPR) SPECTROSCOPY FACILITY
电子顺磁共振 (EPR) 光谱设备
- 批准号:
8360536 - 财政年份:2011
- 资助金额:
$ 16.63万 - 项目类别:
Mitochondrial Redox Systems in Neurogenic Hypertension
神经源性高血压中的线粒体氧化还原系统
- 批准号:
7946689 - 财政年份:2010
- 资助金额:
$ 16.63万 - 项目类别:
Mitochondrial Redox Systems in Neurogenic Hypertension
神经源性高血压中的线粒体氧化还原系统
- 批准号:
8289595 - 财政年份:2010
- 资助金额:
$ 16.63万 - 项目类别:
Mitochondrial Redox Systems in Neurogenic Hypertension
神经源性高血压中的线粒体氧化还原系统
- 批准号:
8102857 - 财政年份:2010
- 资助金额:
$ 16.63万 - 项目类别:
Mitochondrial Redox Systems in Neurogenic Hypertension
神经源性高血压中的线粒体氧化还原系统
- 批准号:
8484425 - 财政年份:2010
- 资助金额:
$ 16.63万 - 项目类别:
Mitochondrial Redox Systems in Neurogenic Hypertension
神经源性高血压中的线粒体氧化还原系统
- 批准号:
8692571 - 财政年份:2010
- 资助金额:
$ 16.63万 - 项目类别:
A NANOZYME ANTIOXIDANT THERAPY FOR THE TREATMENT OF ANGIOTENSIN II-DEPENDANT HYP
用于治疗血管紧张素 II 依赖性 HYP 的纳米酶抗氧化疗法
- 批准号:
8167876 - 财政年份:2010
- 资助金额:
$ 16.63万 - 项目类别:
A NANOZYME ANTIOXIDANT THERAPY FOR THE TREATMENT OF ANGIOTENSIN II-DEPENDANT HYP
用于治疗血管紧张素 II 依赖性 HYP 的纳米酶抗氧化疗法
- 批准号:
7960470 - 财政年份:2009
- 资助金额:
$ 16.63万 - 项目类别:
ROLE OF MITOCHONDRIAL-PRODUCED ROS IN NEUROGENIC HYPERTENSION
线粒体产生的 ROS 在神经源性高血压中的作用
- 批准号:
7720825 - 财政年份:2008
- 资助金额:
$ 16.63万 - 项目类别:
相似海外基金
Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
- 批准号:
24K18002 - 财政年份:2024
- 资助金额:
$ 16.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
- 批准号:
2222215 - 财政年份:2023
- 资助金额:
$ 16.63万 - 项目类别:
Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
- 批准号:
23K09272 - 财政年份:2023
- 资助金额:
$ 16.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
- 批准号:
10652764 - 财政年份:2023
- 资助金额:
$ 16.63万 - 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
- 批准号:
10730652 - 财政年份:2023
- 资助金额:
$ 16.63万 - 项目类别:
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
- 批准号:
22K11609 - 财政年份:2022
- 资助金额:
$ 16.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
- 批准号:
22K16720 - 财政年份:2022
- 资助金额:
$ 16.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
- 批准号:
RGPIN-2018-04107 - 财政年份:2022
- 资助金额:
$ 16.63万 - 项目类别:
Discovery Grants Program - Individual
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
- 批准号:
RGPIN-2019-05674 - 财政年份:2022
- 资助金额:
$ 16.63万 - 项目类别:
Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
- 批准号:
22K12824 - 财政年份:2022
- 资助金额:
$ 16.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




